Feasibility, Acceptability and Costs of a Multiple First-lines Artemisinin-based Combination Therapies

NCT04265573 · clinicaltrials.gov ↗
COMPLETED
Status
150000
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Groupe de Recherche Action en Sante

Collaborators